BIOMAT Database Logo BIOMAT Database Logo

Sudden death due to atrial fibrillation in hypertrophic cardiomyopathy: a predictable event in a young patient. 2003

Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
Cardiosurgery Division, Department of Emergency and Organ Transplant and D.I.M.C, University of Bari, Italy. sfavale@tin.it

This case refers to a 39-year-old woman with hypertrophic cardiomyopathy (HCM) and family history of sudden death (SD). In 1985, high rate atrial stimulation induced VF. In 1996 an ICD was implanted and she remained without arrhythmic events until November 2000 when the device reported one episode of atrial fibrillation degenerating into VF and terminated by the ICD. The VF induction mechanism recorded by the ICD was similar to that observed in 1985. The high incidence of atrial tachyarrhythmias in HCM renders cases like this at higher risk of SD. The predictive role of incremental atrial stimulation merits highlighting in future studies.

UI MeSH Term Description Entries
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000638 Amiodarone An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. Amiobeta,Amiodarex,Amiodarona,Amiodarone Hydrochloride,Amiohexal,Aratac,Braxan,Corbionax,Cordarex,Cordarone,Kordaron,L-3428,Ortacrone,Rytmarone,SKF 33134-A,Tachydaron,Trangorex,Hydrochloride, Amiodarone,L 3428,L3428,SKF 33134 A,SKF 33134A
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil
D016757 Death, Sudden, Cardiac Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005) Cardiac Sudden Death,Sudden Cardiac Death,Cardiac Arrest, Sudden,Sudden Cardiac Arrest,Arrest, Sudden Cardiac,Cardiac Arrests, Sudden,Cardiac Death, Sudden,Death, Cardiac Sudden,Death, Sudden Cardiac,Sudden Death, Cardiac
D017147 Defibrillators, Implantable Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes. Cardioverter-Defibrillators, Implantable,Implantable Cardioverter Defibrillator,Implantable Cardioverter-Defibrillators,Implantable Defibrillators,Cardioverter Defibrillator, Implantable,Cardioverter Defibrillators, Implantable,Cardioverter-Defibrillator, Implantable,Defibrillator, Implantable,Defibrillator, Implantable Cardioverter,Defibrillators, Implantable Cardioverter,Implantable Cardioverter Defibrillators,Implantable Cardioverter-Defibrillator,Implantable Defibrillator

Related Publications

Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
Sudden death in young people due to hypertrophic cardiomyopathy.
September 1989, Archives of emergency medicine,
Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
September 2006, Journal of cardiovascular medicine (Hagerstown, Md.),
Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
[Left atrial thrombus in a patient with hypertrophic cardiomyopathy and sudden death].
January 1987, Revista espanola de cardiologia,
Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
Sudden cardiac death due to risperidone therapy in a patient with possible hypertrophic cardiomyopathy.
May 2005, The Annals of pharmacotherapy,
Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.
January 2022, Journal of cardiovascular electrophysiology,
Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
Sudden unexpected death due to familial hypertrophic obstructive cardiomyopathy.
July 1990, Forensic science international,
Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
Hypertrophic cardiomyopathy. Sudden death is rare in young people with hypertrophic cardiomyopathy.
July 2006, BMJ (Clinical research ed.),
Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
Sudden unexpected death in young athletes: reconsidering "hypertrophic cardiomyopathy".
April 2009, Pediatrics,
Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
Failure of amiodarone to prevent ventricular fibrillation (sudden death) in hypertrophic cardiomyopathy.
March 1989, The Canadian journal of cardiology,
Stefano Favale, and Carlo Pappone, and Frida Nacci, and Francesco Fino, and Francesco Resta, and Cosimo D Dicandia
Sudden death in hypertrophic cardiomyopathy.
December 2009, Journal of cardiovascular translational research,
Copied contents to your clipboard!